Virtus LifeSci Net Asset

BBP -- USA Etf  

USD 43.83  0.23  0.52%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Net Asset Analysis

Net Asset is current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assest is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Virtus LifeSci 
Net Asset 
Current Market Value 
Current Liabilities 
34.16 M

About Net Asset

Net Asset is the value used in calulating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formullay that uses closing prices of all positions in the fund's portfolio.
Compare to competition
Based on recorded statements Virtus LifeSci Biotech Products ETF has Net Asset of 34.16 M. This is much higher than that of the Virtus family, and significantly higher than that of Health category, The Net Asset for all etfs is over 1000% lower than the firm.

Did you try this?

Run Fundamentals Matrix Now


Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
All  Next Launch Fundamentals Matrix

Virtus LifeSci Institutional Holders

Current Institutional Investors

Security TypeSharesValue
Royal Bank Of CanadaFund Units103.9 K4.6 M

Asset Allocation

Fund Instrument Allocation for Virtus LifeSci

The fund consists of 98.64% investments in stocks, with the rest of investments allocated between various types of exotic instruments.
      Instrument Type 

Fundamental Indicators

Current Virtus LifeSci financial ratios